Grey areas and evidence gaps in the management of rectal cancer as revealed by comparing recommendations from clinical guidelines
Rectal cancers account for 39% of colorectal tumours, and represent the 8th most common malignancy and the 9th leading cause of cancer-related deaths [1]. In 2018, 704,376 new diagnoses and 310,394 deaths for this disease were registered worldwide [1]. The global distribution of rectal cancer is characterised by some geographic variation with incidence rates being higher in Eastern Europe, Australia/New Zealand and Eastern Asia while lower in most African regions and Southern Asia [1]. Rectal cancers are the most common colorectal tumour among people
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: G. Bregni, T. Akin Telli, S. Camera, C. Baratelli, L. Shaza, A. Deleporte, L. Moretti, M.A. Bali, G. Liberale, A. Hendlisz, F. Sclafani Tags: Systematic or Meta-analysis Studies Source Type: research
More News: African Health | Australia Health | Cancer | Cancer & Oncology | Colorectal Cancer | New Zealand Health | Rectal Cancers | Study